Inflammatory Mediators in Atherosclerotic Vascular Remodeling

• Published in: Frontiers in cardiovascular medicine Vol. 9; p. 868934
• Main Authors: Evans, Bryce R, Yerly, Anaïs, van der Vorst, Emiel P C, Baumgartner, Iris, Bernhard, Sarah Maike, Schindewolf, Marc, Döring, Yvonne
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 04.05.2022
• Subjects: atherosclerosis; Cardiovascular Medicine; chemokines; cytokines; inflammatory mediator; remodeling; atherosclerosis; inflammatory mediator; remodeling; cytokines; chemokines
• ISSN: 2297-055X; 2297-055X
• DOI: 10.3389/fcvm.2022.868934

Atherosclerotic vascular disease remains the most common cause of ischemia, myocardial infarction, and stroke. Vascular function is determined by structural and functional properties of the arterial vessel wall, which consists of three layers, namely the adventitia, media, and intima. Key cells in shaping the vascular wall architecture and warranting proper vessel function are vascular smooth muscle cells in the arterial media and endothelial cells lining the intima. Pathological alterations of this vessel wall architecture called vascular remodeling can lead to insufficient vascular function and subsequent ischemia and organ damage. One major pathomechanism driving this detrimental vascular remodeling is atherosclerosis, which is initiated by endothelial dysfunction allowing the accumulation of intimal lipids and leukocytes. Inflammatory mediators such as cytokines, chemokines, and modified lipids further drive vascular remodeling ultimately leading to thrombus formation and/or vessel occlusion which can cause major cardiovascular events. Although it is clear that vascular wall remodeling is an elementary mechanism of atherosclerotic vascular disease, the diverse underlying pathomechanisms and its consequences are still insufficiently understood.